Poster: CLL-129 BRUIN CLL-313: A Phase 3 Open-Label, Randomized Study of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Trial in Progress)

Poster: CLL-129 BRUIN CLL-313: A Phase 3 Open-Label, Randomized Study of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Trial in Progress)

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia Vol. 22; p. S145
Main Authors: Levy, Alex, Jurczak, Wojciech, Dartigeas, Caroline, Coscia, Marta, Ganly, Peter S., Al-Jazayrly, Ghassan, Wang, Chunxiao, Bao, Katherine, Leow, Ching Ching, Shahda, Safi, Zinzani, Pier Luigi
Format: Journal Article
Language:English
Published: 01-10-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:2152-2650
DOI:10.1016/S2152-2650(22)00879-5